Bank of New York Mellon’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Sell
187,519
-4,105
-2% -$10.4K ﹤0.01% 3713
2026
Q1
$376K Sell
191,624
-3,296
-2% -$7.73K ﹤0.01% 3732
2025
Q4
$528K Buy
194,920
+21,978
+13% +$72.1K ﹤0.01% 3583
2025
Q3
$732K Sell
172,942
-2,840
-2% -$12.5K ﹤0.01% 3384
2025
Q2
$875K Sell
175,782
-7,160
-4% -$31.1K ﹤0.01% 3206
2025
Q1
$807K Sell
182,942
-9,670
-5% -$45.4K ﹤0.01% 3180
2024
Q4
$896K Buy
192,612
+17,633
+10% +$96.9K ﹤0.01% 3220
2024
Q3
$1.21M Buy
174,979
+8,002
+5% +$62.8K ﹤0.01% 3025
2024
Q2
$1.3M Sell
166,977
-5,597
-3% -$41.5K ﹤0.01% 3045
2024
Q1
$1.23M Sell
172,574
-33,069
-16% -$219K ﹤0.01% 3038
2023
Q4
$1.38M Buy
205,643
+16,083
+8% +$90.6K ﹤0.01% 3020
2023
Q3
$1.07M Buy
189,560
+13,235
+8% +$88.2K ﹤0.01% 3108
2023
Q2
$973K Buy
176,325
+3,268
+2% +$17.6K ﹤0.01% 3209
2023
Q1
$1.08M Sell
173,057
-15,680
-8% -$87.4K ﹤0.01% 3101
2022
Q4
$880K Buy
188,737
+143,145
+314% +$705K ﹤0.01% 3255
2022
Q3
$213K Sell
45,592
-2,480
-5% -$15.6K ﹤0.01% 3990
2022
Q2
$284K Buy
48,072
+8,797
+22% +$97.9K ﹤0.01% 3914
2022
Q1
$759K Buy
39,275
+412
+1% +$9.45K ﹤0.01% 3473
2021
Q4
$1.27M Sell
38,863
-733
-2% -$29.5K ﹤0.01% 3251
2021
Q3
$1.62M Buy
39,596
+4,999
+14% +$181K ﹤0.01% 3117
2021
Q2
$1.25M Buy
34,597
+10,124
+41% +$374K ﹤0.01% 3277
2021
Q1
$955K Sell
24,473
-5,157
-17% -$232K ﹤0.01% 3355
2020
Q4
$1.2M Buy
+29,630
New +$1.36M ﹤0.01% 3163

Other funds holding GDRX

Bank of New York Mellon's GDRX Position: Q2 2026 in Review

Bank of New York Mellon reduced its GoodRx Holdings (GDRX) stake by 2.1% in Q2 2026, selling an estimated $10.4K and leaving 187,519 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

Bank of New York Mellon first reported a position in GDRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.62M in Q3 2021. 73 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Bank of New York Mellon held 187,519 shares of GoodRx Holdings worth $540K as of Q2 2026.
  • Bank of New York Mellon sold 4,105 GoodRx Holdings shares in Q2 2026, an estimated $10.4K.
  • GoodRx Holdings made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3713 holding.
  • Bank of New York Mellon first reported a position in GoodRx Holdings in Q4 2020 and has held it in 23 quarters since.
  • Bank of New York Mellon's GoodRx Holdings position peaked at $1.62M in Q3 2021.
  • 73 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.